Black Rock Inc. Nektar Therapeutics Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
20Shares Held
16.1MCall Options Held
0Put Options Held
0-
Jpmorgan Chase & CO New York, NY491KShares$11.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$7.71 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$1.22 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ18.6KShares$438,1810.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO12KShares$283,2000.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.42B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...